Breast Cancer Risk Prediction
Take early action to reduce your breast cancer risk.
MammoReady™ is a DNA Test done to help you understand your risks of developing breast cancer and plan for a better future.
- Understand your unique genetic and clinical factors, helping you assess your specific breast cancer risk.
- Take proactive steps with earlier screenings and targeted prevention strategies based on your genetic profile.
- Make informed choices about your health, backed by comprehensive data that helps you manage your risk effectively.
Backed by Science, Built for You
MammoReady™ helps you understand your personal breast cancer risk and take proactive steps by providing a comprehensive genetic report that includes three types of risk factors:
-
Polygenic Risk:
This looks at 313 genetic markers (SNPs) related to breast cancer, providing an overview of your genetic predisposition to the disease.
-
Monogenic Risk:
Focuses on key genes, such as BRCA1 ,BRCA2, and PALB2 that are directly associated with a higher risk of breast cancer.
-
Clinical Risk:
Takes into account personal factors like family history, lifestyle, and medical history to assess your risk further.
Who Can Benefit from MammoReady™?
This test is highly recommended for women aged 25–75 years.
This test is aimed at enabling earlier access to clinical breast examination for women below the recommended screening age in national guidelines (35–49 years).
Women aged 25–75 years who:
- Have a moderate risk of breast cancer based on family history
- Do not have known genetic predisposition to BRCA1, BRCA2, or PALB2
- Have inconclusive breast screening results or breast cancer–related symptoms
Why Choose Breast Cancer Risk Prediction
We have 2x improvement in sensitivity compared to BRCA1/2 screening and 2x high risk individuals correctly identified using combined risk approach, also we correctly categorized 10% of individuals from previous risk categorization using traditional risk assesment.
MammoReady™ can help you:
Analytical sensitivity dan specificity > 98%
Receive a complete report on genetic and clinical risks
Get advice on lifestyle, screenings, and monitoring
Fast, Secure, & Science-Backed Testing
- Turnaround Time: 2-4 weeks
- Analysis at Nalagenetic Pte Ltd (Indonesia)
- Using microarray Illumina GSAv3
- Confirmatory testing of positive monogenic genes using Next-generation Sequencing
What Happens After You Get Your Results?
What Report Do I Get?
Understand your risk in the next 5 years
MammoReady™ helps you understand your breast cancer risk and take proactive steps.
This test provides a genetic report covering three types of risks:
-
Polygenic Risk:
Using a model designed for breast cancer, we examine 313 single nucleotide polymorphisms (SNPs).
-
Monogenic Risk:
Focuses on key genes associated with breast cancer, including BRCA 1, BRCA 2, and PALB2.
-
Clinical Risk:
Includes family history, lifestyle, and medical history.
Find the right DNA test for you and your loved ones
Unlock total genetic insights to guide your health, nutrition, and wellness journey with personalized and preventive precision
For Individuals
Find our DNA Test product to align with your Goals
